Literature DB >> 24973456

Critical roles of TIPE2 protein in murine experimental colitis.

Yunwei Lou1, Honghong Sun2, Samantha Morrissey2, Thomas Porturas2, Suxia Liu3, Xianxin Hua4, Youhai H Chen5.   

Abstract

Both commensal bacteria and infiltrating inflammatory cells play essential roles in the pathogenesis of inflammatory bowel disease. The molecular mechanisms whereby these pathogenic factors are regulated during the disease are not fully understood. We report in this article that a member of the TNF-α-induced protein 8 (TNFAIP8) family called TIPE2 (TNFAIP8-like 2) plays a crucial role in regulating commensal bacteria dissemination and inflammatory cell function in experimental colitis induced by dextran sodium sulfate (DSS). Following DSS treatment, TIPE2-deficient mice, or chimeric mice that are deficient in TIPE2 only in their hematopoietic cells, lost less body weight and survived longer than wild-type controls. Consistent with this clinical observation, TIPE2-deficient mice exhibited significantly less severe colitis and colonic damage. This was associated with a marked reduction in the colonic expression of inflammatory cytokines, such as TNF-α, IL-6, and IL-12. Importantly, the ameliorated DSS-induced colitis in TIPE2(-/-) mice also was associated with reduced local dissemination of commensal bacteria and a weaker systemic inflammatory response. Combined with our previous report that TIPE2 is a negative regulator of antibacterial immunity, these results indicate that TIPE2 promotes colitis by inhibiting mucosal immunity to commensal bacteria.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24973456      PMCID: PMC4108503          DOI: 10.4049/jimmunol.1400415

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP.

Authors:  Florencia E Castaneda; Baljit Walia; Matam Vijay-Kumar; Neal R Patel; Susanne Roser; Vasantha L Kolachala; Mauricio Rojas; Lixin Wang; Gabriela Oprea; Pallavi Garg; Andrew T Gewirtz; Jesse Roman; Didier Merlin; Shanthi V Sitaraman
Journal:  Gastroenterology       Date:  2005-12       Impact factor: 22.682

2.  A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice.

Authors:  I Okayasu; S Hatakeyama; M Yamada; T Ohkusa; Y Inagaki; R Nakaya
Journal:  Gastroenterology       Date:  1990-03       Impact factor: 22.682

Review 3.  Involvement of innate immunity in the development of inflammatory and autoimmune diseases.

Authors:  Helena Tlaskalová-Hogenová; Ludmila Tucková; Renata Stepánková; Tomás Hudcovic; Lenka Palová-Jelínková; Hana Kozáková; Pavel Rossmann; Daniel Sanchez; Jana Cinová; Tomás Hrncír; Miloslav Kverka; Lenka Frolová; Holm Uhlig; Fiona Powrie; Paul Bland
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

Review 4.  The fundamental basis of inflammatory bowel disease.

Authors:  Warren Strober; Ivan Fuss; Peter Mannon
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

5.  Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial.

Authors:  B J Rembacken; A M Snelling; P M Hawkey; D M Chalmers; A T Axon
Journal:  Lancet       Date:  1999-08-21       Impact factor: 79.321

6.  Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation.

Authors:  Brendan A Hilliard; Nicola Mason; Lingyun Xu; Jing Sun; Salah-Eddine Lamhamedi-Cherradi; Hsiou-Chi Liou; Christopher Hunter; Youhai H Chen
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

7.  Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study.

Authors:  U M Turunen; M A Färkkilä; K Hakala; K Seppälä; A Sivonen; M Ogren; M Vuoristo; V V Valtonen; T A Miettinen
Journal:  Gastroenterology       Date:  1998-11       Impact factor: 22.682

8.  The expression and significance of TIPE2 in peripheral blood mononuclear cells from asthmatic children.

Authors:  Y Ma; X Liu; Z Wei; X Wang; Z Wang; W Zhong; Y Li; F Zhu; C Guo; L Zhang; X Wang
Journal:  Scand J Immunol       Date:  2013-12       Impact factor: 3.487

9.  Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice.

Authors:  L A Dieleman; B U Ridwan; G S Tennyson; K W Beagley; R P Bucy; C O Elson
Journal:  Gastroenterology       Date:  1994-12       Impact factor: 22.682

10.  Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice.

Authors:  H C Rath; M Schultz; R Freitag; L A Dieleman; F Li; H J Linde; J Schölmerich; R B Sartor
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

View more
  20 in total

1.  TIPE2 acts as a negative regulator linking NOD2 and inflammatory responses in myocardial ischemia/reperfusion injury.

Authors:  Hongyu Zhang; Tianfeng Zhu; Wenwen Liu; Xin Qu; Ye Chen; Ping Ren; Ziying Wang; Xinbing Wei; Yan Zhang; Fan Yi
Journal:  J Mol Med (Berl)       Date:  2015-04-17       Impact factor: 4.599

2.  Adenovirus-mediated TIPE2 overexpression inhibits gastric cancer metastasis via reversal of epithelial-mesenchymal transition.

Authors:  H Yin; X Huang; M Tao; Q Hu; J Qiu; W Chen; J Wu; Y Xie
Journal:  Cancer Gene Ther       Date:  2017-02-10       Impact factor: 5.987

Review 3.  Regulation of inflammation and tumorigenesis by the TIPE family of phospholipid transfer proteins.

Authors:  Jason R Goldsmith; Svetlana Fayngerts; Youhai H Chen
Journal:  Cell Mol Immunol       Date:  2017-03-13       Impact factor: 11.530

4.  Adenovirus-directed expression of TIPE2 suppresses gastric cancer growth via induction of apoptosis and inhibition of AKT and ERK1/2 signaling.

Authors:  Y Zhu; M Tao; J Wu; Y Meng; C Xu; Y Tian; X Zhou; J Xiang; H Zhang; Y Xie
Journal:  Cancer Gene Ther       Date:  2016-03-18       Impact factor: 5.987

5.  TIPE2 Promotes Tumor Initiation But Inhibits Tumor Progression in Murine Colitis-Associated Colon Cancer.

Authors:  Zienab Etwebi; Jason R Goldsmith; Mayassa Bou-Dargham; Yuhua Tian; Ryan Hood; Nina Spitofsky; Mingyue Li; Honghong Sun; Yunwei Lou; Suxia Liu; Christopher Lengner; Youhai H Chen
Journal:  Inflamm Bowel Dis       Date:  2022-05-04       Impact factor: 7.290

6.  Clinical Significance of TIPE2 Protein Upregulation in Non-Hodgkin's Lymphoma.

Authors:  Chunyan Hao; Na Zhang; Minghong Geng; Qing Ren; Yan Li; Yan Wang; Youhai H Chen; Suxia Liu
Journal:  J Histochem Cytochem       Date:  2016-09       Impact factor: 2.479

7.  In Silico Analysis of Tumor Necrosis Factor α-Induced Protein 8-Like-1 (TIPE1) Protein.

Authors:  Pei Shen; Hong Zhang; Zhaoliang Su; Shengjun Wang; Huaxi Xu
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

8.  Effect of Melilotus extract on lung injury via the upregulation of tumor necrosis factor-α-induced protein-8-like 2 in septic mice.

Authors:  Ming-Wei Liu; Mei-Xian Su; Yun-Hui Wang; Chuan-Yun Qian
Journal:  Mol Med Rep       Date:  2014-11-17       Impact factor: 2.952

9.  TIPE1 Suppresses Growth and Metastasis of Ovarian Cancer.

Authors:  Zhenyu Zhang; Minghui Chang; Xingguo Song; Kangyu Wang; Wenjuan Sun; Hongxin Ma; Xiaohui Yan; Yuhong Sun; Xianrang Song; Li Xie
Journal:  J Oncol       Date:  2021-06-03       Impact factor: 4.375

10.  TIPE2 mRNA Level in PBMCs Serves as a Novel Biomarker for Predicting Short-Term Mortality of Acute-on-Chronic Hepatitis B Liver Failure: A Prospective Single-Center Study.

Authors:  Yu-Chen Fan; Na Wang; Yan-Yan Sun; Xiao-Yan Xiao; Kai Wang
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.